A former Network Rail employee's fight against dismissal for using prescribed medical cannabis is now before the Employment Appeal Tribunal, in a case that could transform how UK rail companies handle disability discrimination and safety-critical roles.
The worker, who held a safety-critical position, was sacked after testing positive for cannabis despite providing evidence of a valid medical prescription. The initial Employment Tribunal ruled the dismissal was justified on health and safety grounds, but this decision is now under appeal.
The case hinges on whether Network Rail could have made reasonable adjustments to accommodate the employee's medical condition and prescribed treatment without compromising safety. The Employment Appeal Tribunal must consider whether the original tribunal erred in its assessment of disability discrimination and the employer's duty under the Equality Act 2010.
Central to the legal challenge is a detailed examination of risks associated with medical cannabis use in safety-critical environments, the possibility of alternative roles, and employers' obligations to avoid discriminating against disabled staff. The case highlights the evolving legal landscape around medical cannabis, which has been legal on prescription in the UK since November 2018.
The tribunal's decision will provide crucial clarity for employers in rail, aviation, and construction, where safety is paramount. Many workplace drug and alcohol policies currently fail to distinguish between recreational and prescribed cannabis use, potentially creating conflicts with disability discrimination laws. The outcome could force a wholesale review of existing policies to ensure compliance with the Equality Act.
For disabled employees who rely on prescribed medical cannabis, the case offers hope for stronger workplace protections. A favourable ruling could ensure their medical needs are considered within reasonable adjustments rather than leading to automatic dismissal, reflecting society's growing recognition of cannabis as legitimate medicine.